Online Networking

How U.S. tech companies can find their perfect match in Chile — for free

You won't want to miss this free virtual event. Photo by WestEnd61/Getty

Beginning October 19, American companies can explore opportunities with Chilean products and services, all without hopping on a plane or spending a dime.

Chile Connected, sponsored by ProChile, is a nearly month-long virtual event designed to serve as a "matchmaker" for technology firms as well as creative industries, healthy food providers, and women-led businesses.

If you're wondering "why Chile?" there are some very solid stats to make you look twice at the South American country. Chile is the 29th largest trading partner of the United States, while we are the No. 1 destination for non-copper goods and service exports from Chile.

Chile is also recognized as the most advanced IT market in Latin America, with a performance that's superior to Argentina, Brazil, Colombia, and Peru. The IT sector there represents 3.4 percent of its national GDP.

Chile has had a long and prosperous history of trade with the U.S., particularly in the 16 years since the implementation of the TLC agreement. This treaty has allowed trade to increase over 220 percent between both countries over this time period.

So now that Chile's got your attention, mark your calendar for October 27-29, when the tech and innovation panel will welcome high-level experts and keynote speakers from both markets in the areas of HealthTech, EdTech, FinTech, and RetailTech.

A study done by the Ministry of Sciences in March 2020 indicates that 13 percent of Chilean startup companies with a scientific and technological base are related to the area of health.

If you're specifically looking for companies that specialize in biotech or biomedicine, digital (AI, deep/machine learning, IOT, and big data) technologies, or a combination of these, this would be the event to find them.

Fifty-three percent of Chilean companies like these have stated they need a joint venture in order to explore other markets, and the recent success of companies like GenoSUR and Levita have proven the market is ready for partnerships (you'll hear from top-tier leaders at both during the panel).

Chilean RetailTech providers have demonstrated to be a generation of highly sophisticated and specialized tech service providers, while their FinTech specialists aim to satisfy the needs of this demanding segment within the U.S. market.

Register for your free spot here, and gear up to find your next great international tech match.

Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News